A risk-off semis tape gave quantum no real leadership — Bruker only bounced off its earnings crash, AMD led the decliners, and the pure-play names sold off on beta with no quantum-specific catalyst.

There was no genuine leadership in the quantum stack — its best performer was a rebound, not a breakout. Bruker rose +4.3% to $52.47, but only after cratering roughly 18-22% the prior session on a Q2 that missed on revenue (organic growth just 2.8%, "at the low end") and carried a full-year guidance cut to $3.56B from $3.59B, with ~$20M of semiconductor revenue slipping from Q3 into Q4. Bruker anchors the measurement-and-metrology choke — the instruments that characterize qubits and materials — so a dead-cat bounce is the honest read here, not a signal. The tape's real character was defensive.

The laggard was AMD, off −7.0% to $482.05, and it dragged the compute-adjacent layer of the vertical with it. AMD's Q2 was a clean beat — EPS $1.66, revenue $11.54B, data-center revenue more than doubling to $6.7B — but the stock had run ~140% into the print, a 54% gross margin missed the ~56% consensus on Helios AI-ramp costs, and a $13B Q3 guide wasn't enough. In a vertical where classical accelerators and control electronics gate the quantum-classical loop, AMD's de-rate set the risk tone. FormFactor, the cryogenic-probe and advanced-packaging name, fell −4.9% to $114.44, and GlobalFoundries dropped −4.9%.

The tell was the pure-plays, which sold off on beta with no company-specific news — a positioning move, not a fundamental one. IonQ fell −4.3% to $39.93, Rigetti −3.8% to $16.78, Quantum Computing Inc −3.8%, and D-Wave −2.0%, while the isotope-and-materials choke also leaked: ASP Isotopes −5.6% and Infleqtion −5.3%. The scarce green came from the supply-chain edges — NVIDIA +3.4%, ATI +2.5% at the specialty-metals choke, Coherent +1.4% on photonics, and Gooch & Housego +3.5% — plus IBM holding roughly flat. Nothing in the session reflected a shift in quantum roadmaps; it reflected the AI-semis complex de-risking into a heavy earnings week.

The calendar is where conviction gets tested. IonQ reports Q2 on August 12 and ASP Isotopes the same week (with a Renergen helium update around August 14), the first pure-play read on bookings since the selloff. Coherent's Q4 lands August 13 and Keysight's fiscal Q3 August 18 — the photonics and test-and-measurement choke — before NVIDIA on August 26. Further out, the National Quantum Initiative Reauthorization Act floor votes are pending in September and the DARPA Quantum Benchmarking Initiative's Stage B-to-C down-select runs into November-December, the funding and validation gates that matter more to this vertical than any single session's tape.